Abstracts from the NCRI Cancer Conference
Menu
Skip to content
Home
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
227
abstracts found.
Results filter
Session type: Symposia
Remove Filter
Studying therapy response and resistance in mouse models of human breast cancer
Year:
2011
Session type:
Symposia
Jos Jonkers
1
1
Netherlands Cancer Institute, Amsterdam, The Netherlands
Introduction: Epigenetics and cancer
Year:
2011
Session type:
Symposia
Peter D. Adams
1
1
Institute of Cancer Sciences, Glasgow, UK
Tailoring treatment in lung cancer
Year:
2011
Session type:
Symposia
Jean-Charles Soria
1
1
Institut Gustave Roussy, Villejuif, France
Parallel clinical trials in cells, mice and patients to define the genetic bases of response and resistance to targeted therapies in CRCs
Year:
2011
Session type:
Symposia
Alberto Bardelli
1
TO
University of Torino-Medical School, Candiolo
The challenges for the implementation of molecular diagnostics in the clinical setting
Year:
2011
Session type:
Symposia
David Gonzalez de Castro
1
1
The Institute of Cancer Research, London, UK
Introduction: Transformational impact of symptom control for cancer patients
Year:
2011
Session type:
Symposia
Peter Selby
1
1
Cancer Research UK Centre, Leeds, UK
Overview on how symptom control and dealing with toxicity has changed over the last decade and enabled the delivery of more complex and effective treatment
Year:
2011
Session type:
Symposia
Martin Gore
1
1
Royal Marsden Hospital, London, UK
Cancer and bone – minimizing the clinical impact of bone complications
Year:
2011
Session type:
Symposia
Robert Coleman
1
1
Weston Park Hospital, Sheffield, UK
Work and cancer survivors
Year:
2011
Session type:
Symposia
Michael Feuerstein
1
1
Uniformed Services University, Bethesda Maryland, USA
Introduction: Colorectal cancer screening in the United Kingdom: Successes, failures and future developments
Year:
2011
Session type:
Symposia
Robert Steele
1
1
University of Dundee, Dundee, UK
Food, nutrition, physical activity, and cancer prevention: evidence and recommendations
Year:
2011
Session type:
Symposia
Martin Wiseman
1
1
WCRF International, London, UK
Chemoprevention successes and surprises
Year:
2011
Session type:
Symposia
John Baron
1
1
University of North Carolina, Chapel Hill, NC, USA
Polygenic risk prediction: The clinical significance
Year:
2012
Session type:
Symposia
Paul Pharoah
University of Cambridge, UK
Unexplained familial breast cancer risk – how can we find the missing genes?
Year:
2012
Session type:
Symposia
Julian Peto
London School of Hygiene and Tropical Medicine, UK
Interrogating regulatory networks to elucidate drivers of tumourigenesis, progression, and drug sensitivity
Year:
2012
Session type:
Symposia
Andrea Califano
Columbia University, New York, USA
Recent advances in breast, cervix and oral cancer early detection and prevention in low and middle income countries
Year:
2012
Session type:
Symposia
Rengaswamy Sankaranarayanan
International Agency for Research on Cancer, World Health Organization, Lyon, France
Cancer Control for India and Developing World
Year:
2012
Session type:
Symposia
Rajendra Badwe
Tata Memorial Centre, Mumbai, India
Oncology drug development in 2012 – Challenges and opportunities of stratified patient populations
Year:
2012
Session type:
Symposia
Susan Galbraith
AstraZeneca, Macclesfield, UK
Translating pre-clinical hypotheses into the clinic – a tale of two kinases
Year:
2012
Session type:
Symposia
Nigel Brooks
AstraZeneca, Macclesfield, UK
Developing novel anti-cancer therapies: Promises and challenges
Year:
2012
Session type:
Symposia
Jeff Evans
The Beatson Institute for Cancer Research, University of Glasgow & NHS Greater Glasgow and Clyde, Glasgow, UK
Delivering on the promise of personalised medicine.
Year:
2012
Session type:
Symposia
Gordon Mills
The University of Texas MD Anderson Cancer Center, USA
Targeting cancer cells and promoting the immune effectors: From models to the clinic
Year:
2012
Session type:
Symposia
Adrian Hayday
King's College London, UK
Live imaging of the earliest inflammatory response to transformed cells within tissues – studies in zebrafish
Year:
2012
Session type:
Symposia
Paul Martin
University of Bristol, UK
Peptide antigen characterization for clinical immunotherapy studies
Year:
2012
Session type:
Symposia
Hans-Georg Rammensee
University of Tübingen, Germany
PD-1 and LAG-3 in Cancer Immunotherapy
Year:
2012
Session type:
Symposia
Charles Drake
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Understanding cancer as a microevolutionary process
Year:
2012
Session type:
Symposia
Gerard Evans
University of Cambridge, UK
Recent insights into the tempo and mode of somatic evolution
Year:
2012
Session type:
Symposia
Carlo Maley
The University of California, San Francisco, USA
Evolutionary complexity in childhood acute lymphoblastic leukaemia
Year:
2012
Session type:
Symposia
Mel Greaves
The Institute of Cancer Research, London, UK
Evolution of cancer genomes
Year:
2012
Session type:
Symposia
Peter Campbell
Wellcome Trust Sanger Institute, Cambridge, UK
Improvements in palliative and supportive care: recent advances
Year:
2012
Session type:
Symposia
Irene Higginson
Cicely Saunders Institute, King’s College London, UK
Advances, challenges and opportunities in symptom management in older patients with cancer
Year:
2012
Session type:
Symposia
Deborah Dudgeon
Queen's University, Ontario, Canada
Recent advances in developing a national end of life care register
Year:
2012
Session type:
Symposia
Carl Johan Fürst
Karolinska Institutet, Stockholm, Sweden
Recent advances in the detection and management of psychological distress and depression in cancer and palliative care
Year:
2012
Session type:
Symposia
Mari Lloyd-Williams
University of Liverpool, UK
Lung cancer – state of the art and science
Year:
2012
Session type:
Symposia
Fergus Macbeth
Wales Cancer Trials Unit, Cardiff, UK
The application of translational science in non-small cell lung cancer (NSCLC): Successes, failures and pitfalls
Year:
2012
Session type:
Symposia
Frances Shepherd
University of Toronto and Princess Margaret Hospital, Ontario, Canada
Lung Stereotactic Ablative Radiotherapy (SABR): The state of the art
Year:
2012
Session type:
Symposia
Kevin Franks
St James's Institute of Oncology, Leeds, UK
Radical radiotherapy for locally advanced NSCLC – Current research and controversies
Year:
2012
Session type:
Symposia
Corinne Faivre-Finn
The Christie NHS Foundation Trust, Manchester, UK
Tumour- environment interactions
Year:
2012
Session type:
Symposia
Margaret Frame
Edinburgh Cancer Research Centre, UK
Tumour-stroma interactions in breast cancer metastasis
Year:
2012
Session type:
Symposia
Clare Isacke
The Institute of Cancer Research, London, UK
Prognostic, predictive and therapeutic potential of PDGFR-positive cancer-associated fibroblasts
Year:
2012
Session type:
Symposia
Arne Östman
Karolinska Institutet, Stockholm, Sweden
Intravital microscopy of tumour cells and their microenvironment through imaging windows
Year:
2012
Session type:
Symposia
Jacco van Rheenen
Hubrecht Institute, Utrecht, The Netherlands
Where next with genome-wide association studies?
Year:
2012
Session type:
Symposia
Bruce Ponder
Cancer Research UK Cambridge Research Institute, UK
Cancer in low and middle income countries – an increasing threat to development
Year:
2012
Session type:
Symposia
Ian Magrath
International Network for Cancer Treatment and Research (INCTR), Brussels, Belgium
Descriptive epidemiology of cancer in developing countries and its importance to cancer control
Year:
2012
Session type:
Symposia
D. Maxwell Parkin
Clinical Trial Service Unit, University of Oxford & Cancer Registry Programme, International Network for Cancer Treatment and Research, Oxford, UK
Illuminating cancer biology with optoacoustic and thermoacoustic imaging
Year:
2013
Session type:
Symposia
Vasilis Ntziachristos
1
1
Helmholtz Zentrum München and Technical University Munich, Munich, Germany
Treatment-induced pain in cancer patients
Year:
2013
Session type:
Symposia
Michael Bennett
1
1
University of Leeds, Leeds, UK
Treatment-induced pain in cancer patients
Year:
2013
Session type:
Symposia
Patrick Dougherty
1
1
The University of Texas MD Anderson Cancer Center, Houston, USA
Update on targeted treatments for painful neuropathy
Year:
2013
Session type:
Symposia
Marie Fallon
1
1
IGMM Edinburgh Cancer Research Centre
Epidemiology and risk factors for persistent pain after breast cancer surgery
Year:
2013
Session type:
Symposia
Julie Bruce
1
1
University of Warwick, Coventry, UK
Clinical decision support systems
Year:
2013
Session type:
Symposia
Willie Hamilton
1
1
Peninsula College of Medicine and Dentistry, Exeter, UK
Page 2 of 5
« First
«
...
2
...
»
Last »